Colorectal Cancer Molecular Diagnostics Market, Global Outlook and Forecast 2022-2028

April 2022 | 65 pages | ID: C16ED3DDD6A7EN
Market Monitor Global

Abstracts

Colorectal cancer molecular diagnostics can speed up the identification of colorectal cancer to provide patients with more treatment options. Individualized and targeted treatments are reshaping the colorectal molecular diagnostics market. Molecular pathology is a key factor to personalized medicine. Increasing adoption of high throughput sequencing technologies and identification of therapeutic targets has led to the development of many colorectal molecular diagnostic tests, which are superior to the conventional colorectal cancer molecular diagnostics tests.

This report contains market size and forecasts of Colorectal Cancer Molecular Diagnostics in Global, including the following market information:

Global Colorectal Cancer Molecular Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Colorectal Cancer Molecular Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

PCR Diagnostics Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Colorectal Cancer Molecular Diagnostics include Agilent, Hologic, Qiagen, Roche, Bayer, Abbott, Grifols, Danaher and Siemens, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Colorectal Cancer Molecular Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Colorectal Cancer Molecular Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Colorectal Cancer Molecular Diagnostics Market Segment Percentages, by Type, 2021 (%)

• PCR Diagnostics
• Mass spectrometry Diagnostics
• Others

Global Colorectal Cancer Molecular Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Colorectal Cancer Molecular Diagnostics Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Laboratories

Global Colorectal Cancer Molecular Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Colorectal Cancer Molecular Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Colorectal Cancer Molecular Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Colorectal Cancer Molecular Diagnostics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Agilent
• Hologic
• Qiagen
• Roche
• Bayer
• Abbott
• Grifols
• Danaher
• Siemens
• BD
• Biom?rieux
• Sysmex

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Colorectal Cancer Molecular Diagnostics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Colorectal Cancer Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL COLORECTAL CANCER MOLECULAR DIAGNOSTICS OVERALL MARKET SIZE

2.1 Global Colorectal Cancer Molecular Diagnostics Market Size: 2021 VS 2028
2.2 Global Colorectal Cancer Molecular Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Colorectal Cancer Molecular Diagnostics Players in Global Market
3.2 Top Global Colorectal Cancer Molecular Diagnostics Companies Ranked by Revenue
3.3 Global Colorectal Cancer Molecular Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Colorectal Cancer Molecular Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Colorectal Cancer Molecular Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Colorectal Cancer Molecular Diagnostics Players in Global Market
  3.6.1 List of Global Tier 1 Colorectal Cancer Molecular Diagnostics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Colorectal Cancer Molecular Diagnostics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Colorectal Cancer Molecular Diagnostics Market Size Markets, 2021 & 2028
  4.1.2 PCR Diagnostics
  4.1.3 Mass spectrometry Diagnostics
  4.1.4 Others
4.2 By Type - Global Colorectal Cancer Molecular Diagnostics Revenue & Forecasts
  4.2.1 By Type - Global Colorectal Cancer Molecular Diagnostics Revenue, 2017-2022
  4.2.2 By Type - Global Colorectal Cancer Molecular Diagnostics Revenue, 2023-2028
  4.2.3 By Type - Global Colorectal Cancer Molecular Diagnostics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Colorectal Cancer Molecular Diagnostics Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Ambulatory Surgical Centers
  5.1.4 Diagnostic Laboratories
5.2 By Application - Global Colorectal Cancer Molecular Diagnostics Revenue & Forecasts
  5.2.1 By Application - Global Colorectal Cancer Molecular Diagnostics Revenue, 2017-2022
  5.2.2 By Application - Global Colorectal Cancer Molecular Diagnostics Revenue, 2023-2028
  5.2.3 By Application - Global Colorectal Cancer Molecular Diagnostics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Colorectal Cancer Molecular Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global Colorectal Cancer Molecular Diagnostics Revenue & Forecasts
  6.2.1 By Region - Global Colorectal Cancer Molecular Diagnostics Revenue, 2017-2022
  6.2.2 By Region - Global Colorectal Cancer Molecular Diagnostics Revenue, 2023-2028
  6.2.3 By Region - Global Colorectal Cancer Molecular Diagnostics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Colorectal Cancer Molecular Diagnostics Revenue, 2017-2028
  6.3.2 US Colorectal Cancer Molecular Diagnostics Market Size, 2017-2028
  6.3.3 Canada Colorectal Cancer Molecular Diagnostics Market Size, 2017-2028
  6.3.4 Mexico Colorectal Cancer Molecular Diagnostics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Colorectal Cancer Molecular Diagnostics Revenue, 2017-2028
  6.4.2 Germany Colorectal Cancer Molecular Diagnostics Market Size, 2017-2028
  6.4.3 France Colorectal Cancer Molecular Diagnostics Market Size, 2017-2028
  6.4.4 U.K. Colorectal Cancer Molecular Diagnostics Market Size, 2017-2028
  6.4.5 Italy Colorectal Cancer Molecular Diagnostics Market Size, 2017-2028
  6.4.6 Russia Colorectal Cancer Molecular Diagnostics Market Size, 2017-2028
  6.4.7 Nordic Countries Colorectal Cancer Molecular Diagnostics Market Size, 2017-2028
  6.4.8 Benelux Colorectal Cancer Molecular Diagnostics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Colorectal Cancer Molecular Diagnostics Revenue, 2017-2028
  6.5.2 China Colorectal Cancer Molecular Diagnostics Market Size, 2017-2028
  6.5.3 Japan Colorectal Cancer Molecular Diagnostics Market Size, 2017-2028
  6.5.4 South Korea Colorectal Cancer Molecular Diagnostics Market Size, 2017-2028
  6.5.5 Southeast Asia Colorectal Cancer Molecular Diagnostics Market Size, 2017-2028
  6.5.6 India Colorectal Cancer Molecular Diagnostics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Colorectal Cancer Molecular Diagnostics Revenue, 2017-2028
  6.6.2 Brazil Colorectal Cancer Molecular Diagnostics Market Size, 2017-2028
  6.6.3 Argentina Colorectal Cancer Molecular Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Colorectal Cancer Molecular Diagnostics Revenue, 2017-2028
  6.7.2 Turkey Colorectal Cancer Molecular Diagnostics Market Size, 2017-2028
  6.7.3 Israel Colorectal Cancer Molecular Diagnostics Market Size, 2017-2028
  6.7.4 Saudi Arabia Colorectal Cancer Molecular Diagnostics Market Size, 2017-2028
  6.7.5 UAE Colorectal Cancer Molecular Diagnostics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Agilent
  7.1.1 Agilent Corporate Summary
  7.1.2 Agilent Business Overview
  7.1.3 Agilent Colorectal Cancer Molecular Diagnostics Major Product Offerings
  7.1.4 Agilent Colorectal Cancer Molecular Diagnostics Revenue in Global Market (2017-2022)
  7.1.5 Agilent Key News
7.2 Hologic
  7.2.1 Hologic Corporate Summary
  7.2.2 Hologic Business Overview
  7.2.3 Hologic Colorectal Cancer Molecular Diagnostics Major Product Offerings
  7.2.4 Hologic Colorectal Cancer Molecular Diagnostics Revenue in Global Market (2017-2022)
  7.2.5 Hologic Key News
7.3 Qiagen
  7.3.1 Qiagen Corporate Summary
  7.3.2 Qiagen Business Overview
  7.3.3 Qiagen Colorectal Cancer Molecular Diagnostics Major Product Offerings
  7.3.4 Qiagen Colorectal Cancer Molecular Diagnostics Revenue in Global Market (2017-2022)
  7.3.5 Qiagen Key News
7.4 Roche
  7.4.1 Roche Corporate Summary
  7.4.2 Roche Business Overview
  7.4.3 Roche Colorectal Cancer Molecular Diagnostics Major Product Offerings
  7.4.4 Roche Colorectal Cancer Molecular Diagnostics Revenue in Global Market (2017-2022)
  7.4.5 Roche Key News
7.5 Bayer
  7.5.1 Bayer Corporate Summary
  7.5.2 Bayer Business Overview
  7.5.3 Bayer Colorectal Cancer Molecular Diagnostics Major Product Offerings
  7.5.4 Bayer Colorectal Cancer Molecular Diagnostics Revenue in Global Market (2017-2022)
  7.5.5 Bayer Key News
7.6 Abbott
  7.6.1 Abbott Corporate Summary
  7.6.2 Abbott Business Overview
  7.6.3 Abbott Colorectal Cancer Molecular Diagnostics Major Product Offerings
  7.6.4 Abbott Colorectal Cancer Molecular Diagnostics Revenue in Global Market (2017-2022)
  7.6.5 Abbott Key News
7.7 Grifols
  7.7.1 Grifols Corporate Summary
  7.7.2 Grifols Business Overview
  7.7.3 Grifols Colorectal Cancer Molecular Diagnostics Major Product Offerings
  7.7.4 Grifols Colorectal Cancer Molecular Diagnostics Revenue in Global Market (2017-2022)
  7.7.5 Grifols Key News
7.8 Danaher
  7.8.1 Danaher Corporate Summary
  7.8.2 Danaher Business Overview
  7.8.3 Danaher Colorectal Cancer Molecular Diagnostics Major Product Offerings
  7.8.4 Danaher Colorectal Cancer Molecular Diagnostics Revenue in Global Market (2017-2022)
  7.8.5 Danaher Key News
7.9 Siemens
  7.9.1 Siemens Corporate Summary
  7.9.2 Siemens Business Overview
  7.9.3 Siemens Colorectal Cancer Molecular Diagnostics Major Product Offerings
  7.9.4 Siemens Colorectal Cancer Molecular Diagnostics Revenue in Global Market (2017-2022)
  7.9.5 Siemens Key News
7.10 BD
  7.10.1 BD Corporate Summary
  7.10.2 BD Business Overview
  7.10.3 BD Colorectal Cancer Molecular Diagnostics Major Product Offerings
  7.10.4 BD Colorectal Cancer Molecular Diagnostics Revenue in Global Market (2017-2022)
  7.10.5 BD Key News
7.11 Biom?rieux
  7.11.1 Biom?rieux Corporate Summary
  7.11.2 Biom?rieux Business Overview
  7.11.3 Biom?rieux Colorectal Cancer Molecular Diagnostics Major Product Offerings
  7.11.4 Biom?rieux Colorectal Cancer Molecular Diagnostics Revenue in Global Market (2017-2022)
  7.11.5 Biom?rieux Key News
7.12 Sysmex
  7.12.1 Sysmex Corporate Summary
  7.12.2 Sysmex Business Overview
  7.12.3 Sysmex Colorectal Cancer Molecular Diagnostics Major Product Offerings
  7.12.4 Sysmex Colorectal Cancer Molecular Diagnostics Revenue in Global Market (2017-2022)
  7.12.5 Sysmex Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Colorectal Cancer Molecular Diagnostics Market Opportunities & Trends in Global Market
Table 2. Colorectal Cancer Molecular Diagnostics Market Drivers in Global Market
Table 3. Colorectal Cancer Molecular Diagnostics Market Restraints in Global Market
Table 4. Key Players of Colorectal Cancer Molecular Diagnostics in Global Market
Table 5. Top Colorectal Cancer Molecular Diagnostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Colorectal Cancer Molecular Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Colorectal Cancer Molecular Diagnostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Colorectal Cancer Molecular Diagnostics Product Type
Table 9. List of Global Tier 1 Colorectal Cancer Molecular Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Colorectal Cancer Molecular Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Colorectal Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Colorectal Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Colorectal Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Colorectal Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Colorectal Cancer Molecular Diagnostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Colorectal Cancer Molecular Diagnostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2023-2028
Table 30. Agilent Corporate Summary
Table 31. Agilent Colorectal Cancer Molecular Diagnostics Product Offerings
Table 32. Agilent Colorectal Cancer Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
Table 33. Hologic Corporate Summary
Table 34. Hologic Colorectal Cancer Molecular Diagnostics Product Offerings
Table 35. Hologic Colorectal Cancer Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
Table 36. Qiagen Corporate Summary
Table 37. Qiagen Colorectal Cancer Molecular Diagnostics Product Offerings
Table 38. Qiagen Colorectal Cancer Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
Table 39. Roche Corporate Summary
Table 40. Roche Colorectal Cancer Molecular Diagnostics Product Offerings
Table 41. Roche Colorectal Cancer Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
Table 42. Bayer Corporate Summary
Table 43. Bayer Colorectal Cancer Molecular Diagnostics Product Offerings
Table 44. Bayer Colorectal Cancer Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
Table 45. Abbott Corporate Summary
Table 46. Abbott Colorectal Cancer Molecular Diagnostics Product Offerings
Table 47. Abbott Colorectal Cancer Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
Table 48. Grifols Corporate Summary
Table 49. Grifols Colorectal Cancer Molecular Diagnostics Product Offerings
Table 50. Grifols Colorectal Cancer Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
Table 51. Danaher Corporate Summary
Table 52. Danaher Colorectal Cancer Molecular Diagnostics Product Offerings
Table 53. Danaher Colorectal Cancer Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
Table 54. Siemens Corporate Summary
Table 55. Siemens Colorectal Cancer Molecular Diagnostics Product Offerings
Table 56. Siemens Colorectal Cancer Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
Table 57. BD Corporate Summary
Table 58. BD Colorectal Cancer Molecular Diagnostics Product Offerings
Table 59. BD Colorectal Cancer Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
Table 60. Biom?rieux Corporate Summary
Table 61. Biom?rieux Colorectal Cancer Molecular Diagnostics Product Offerings
Table 62. Biom?rieux Colorectal Cancer Molecular Diagnostics Revenue (US$, Mn), (2017-2022)
Table 63. Sysmex Corporate Summary
Table 64. Sysmex Colorectal Cancer Molecular Diagnostics Product Offerings
Table 65. Sysmex Colorectal Cancer Molecular Diagnostics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Colorectal Cancer Molecular Diagnostics Segment by Type in 2021
Figure 2. Colorectal Cancer Molecular Diagnostics Segment by Application in 2021
Figure 3. Global Colorectal Cancer Molecular Diagnostics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Colorectal Cancer Molecular Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Colorectal Cancer Molecular Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Colorectal Cancer Molecular Diagnostics Revenue in 2021
Figure 8. By Type - Global Colorectal Cancer Molecular Diagnostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Colorectal Cancer Molecular Diagnostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Colorectal Cancer Molecular Diagnostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Colorectal Cancer Molecular Diagnostics Revenue Market Share, 2017-2028
Figure 12. US Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Colorectal Cancer Molecular Diagnostics Revenue Market Share, 2017-2028
Figure 16. Germany Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 17. France Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Colorectal Cancer Molecular Diagnostics Revenue Market Share, 2017-2028
Figure 24. China Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 28. India Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Colorectal Cancer Molecular Diagnostics Revenue Market Share, 2017-2028
Figure 30. Brazil Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Colorectal Cancer Molecular Diagnostics Revenue Market Share, 2017-2028
Figure 33. Turkey Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Colorectal Cancer Molecular Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 37. Agilent Colorectal Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Hologic Colorectal Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Qiagen Colorectal Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Roche Colorectal Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bayer Colorectal Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Abbott Colorectal Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Grifols Colorectal Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Danaher Colorectal Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Siemens Colorectal Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. BD Colorectal Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Biom?rieux Colorectal Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Sysmex Colorectal Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)